Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling

Autor: Melinda N. Tea, Paul Q. Thomas, Laura Stewart, Dale McAninch, Dominique Jackson, Michael G. Ricos, Leanne M. Dibbens, Sandra Piltz, Ruby Dawson, James N. Hughes, Natasha L. Harvey
Přispěvatelé: Hughes, James, Dawson, Ruby, Tea, Melinda, McAninch, Dale, Piltz, Sandra, Jackson, Dominique, Stewart, Laura, Ricos, Michael G, Dibbens, Leanne M, Harvey, Natasha L, Thomas, Paul
Rok vydání: 2017
Předmět:
0301 basic medicine
Heterozygote
Pathology
medicine.medical_specialty
lcsh:Medicine
Mutagenesis (molecular biology technique)
mTORC1
Mechanistic Target of Rapamycin Complex 1
Biology
medicine.disease_cause
DEPDC5 mutations
Article
gene Depdc5
Mice
03 medical and health sciences
Epilepsy
0302 clinical medicine
Seizures
epilepsy in humans
medicine
Animals
Humans
lcsh:Science
Loss function
Mice
Knockout

Multidisciplinary
GTPase-Activating Proteins
lcsh:R
Brain
Fibroblasts
medicine.disease
Phenotype
Embryonic stem cell
DEPDC5
3. Good health
Disease Models
Animal

030104 developmental biology
Gene Expression Regulation
Multiprotein Complexes
Mutation
Cancer research
lcsh:Q
CRISPR-Cas Systems
biological phenomena
cell phenomena
and immunity

Carcinogenesis
030217 neurology & neurosurgery
Signal Transduction
Zdroj: Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Scientific Reports
ISSN: 2045-2322
Popis: DEPDC5 mutations have recently been shown to cause epilepsy in humans. Evidence from in vitro studies has implicated DEPDC5 as a negative regulator of mTORC1 during amino acid insufficiency as part of the GATOR1 complex. To investigate the role of DEPDC5 in vivo we generated a null mouse model using targeted CRISPR mutagenesis. Depdc5 homozygotes display severe phenotypic defects between 12.5-15.5 dpc, including hypotrophy, anaemia, oedema, and cranial dysmorphology as well as blood and lymphatic vascular defects. mTORC1 hyperactivity was observed in the brain of knockout embryos and in fibroblasts and neurospheres isolated from knockout embryos and cultured in nutrient deprived conditions. Heterozygous mice appeared to be normal and we found no evidence of increased susceptibility to seizures or tumorigenesis. Together, these data support mTORC1 hyperactivation as the likely pathogenic mechanism that underpins DEPDC5 loss of function in humans and highlights the potential utility of mTORC1 inhibitors in the treatment of DEPDC5-associated epilepsy.
Databáze: OpenAIRE